STRATA Skin Sciences (NASDAQ:SSKN – Get Free Report) is anticipated to release its earnings data before the market opens on Wednesday, March 26th. Analysts expect STRATA Skin Sciences to post earnings of ($0.40) per share and revenue of $9.03 million for the quarter.
STRATA Skin Sciences Stock Up 2.7 %
STRATA Skin Sciences stock opened at $2.70 on Wednesday. The firm has a market cap of $11.27 million, a price-to-earnings ratio of -1.02 and a beta of 1.32. The stock has a fifty day simple moving average of $2.80 and a two-hundred day simple moving average of $2.94. STRATA Skin Sciences has a 12 month low of $2.51 and a 12 month high of $5.90. The company has a current ratio of 1.13, a quick ratio of 0.94 and a debt-to-equity ratio of 1.62.
Analyst Ratings Changes
Separately, Maxim Group assumed coverage on STRATA Skin Sciences in a report on Thursday, February 27th. They issued a “buy” rating and a $6.00 target price for the company.
STRATA Skin Sciences Company Profile
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Featured Stories
- Five stocks we like better than STRATA Skin Sciences
- Trading Halts Explained
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- The How And Why of Investing in Oil Stocks
- 3 Must-Own Stocks to Build Wealth This Decade
- What Are Some of the Best Large-Cap Stocks to Buy?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
